Compound Detail
CHEMBL138125
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL138125 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ASHLBSIWNNFRBC-UHFFFAOYSA-N |
3
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
434.3
MW (Da)
5.51
ALogP
6
HBA
2
HBD
87.5
PSA (Ų)
0.31
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 6.62
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | IC50 | 6.62 | 6.62 | 238.0 | 1 |
| NIH3T3 CHEMBL614822 | IC50 | 5.39 | 4.95 | 4060.0 | 2 |
| A-431 CHEMBL614069 | IC50 | 4.94 | 4.94 | 11400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Epidermal growth factor receptor | IC50 | = | 238.0 | nM | 6.62 | In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated... | 13678409 |
| NIH3T3 | IC50 | = | 4060.0 | nM | 5.39 | Selective inhibition of serum stimulated growth of NIH3T3neu isogenic cells | 13678409 |
| A-431 | IC50 | = | 11400.0 | nM | 4.94 | In vitro inhibition of A431 (human carcinoma) cell basal growth. | 13678409 |
| NIH3T3 | IC50 | = | 30550.0 | nM | 4.51 | Selective inhibition of serum stimulated growth of NIH3T3 isogenic cells | 13678409 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 13678409 | 10.1021/jm030142e | NIH3T3 | 2 |
| 13678409 | 10.1021/jm030142e | Epidermal growth factor receptor | 1 |
| 13678409 | 10.1021/jm030142e | A-431 | 1 |
| 13678409 | 10.1021/jm030142e | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine